His primary areas of study are Cognition, Glioma, Quality of life, Internal medicine and Neuropsychology. His Cognition research includes elements of Developmental psychology, Resting state fMRI and Clinical psychology. His work carried out in the field of Glioma brings together such families of science as Neurocognitive and Neuroscience.
His Quality of life research is multidisciplinary, incorporating perspectives in Physical therapy, Surgery and Disease. His research investigates the connection between Internal medicine and topics such as Oncology that intersect with problems in Radiation therapy, Clinical endpoint and Bevacizumab. His study in Neuropsychology is interdisciplinary in nature, drawing from both Verbal memory and Pediatrics.
Martin Klein focuses on Internal medicine, Cognition, Glioma, Oncology and Quality of life. His Internal medicine research includes themes of Neurocognitive, Type 1 diabetes, Surgery and Cardiology. In his study, which falls under the umbrella issue of Cognition, Psychiatry is strongly linked to Clinical psychology.
In Glioma, Martin Klein works on issues like Magnetoencephalography, which are connected to Resting state fMRI. His Oncology research incorporates elements of Bevacizumab, Chemotherapy, Temozolomide, Low-Grade Glioma and Brain tumor. His Quality of life study incorporates themes from Physical therapy, Neurology and Pediatrics.
Martin Klein spends much of his time researching Internal medicine, Cognition, Oncology, Glioma and Neurocognitive. His study in the field of Temozolomide, Bevacizumab, Clinical endpoint and Randomized controlled trial is also linked to topics like In patient. He interconnects Type 1 diabetes and Cognitive decline in the investigation of issues within Cognition.
His Oncology study integrates concerns from other disciplines, such as Progression-free survival, Chemotherapy, Brain tumor, Hazard ratio and Radiation therapy. His research investigates the connection with Glioma and areas like Magnetoencephalography which intersect with concerns in Epilepsy. His Neurocognitive research is multidisciplinary, relying on both Quality of life, Health related quality of life, Quality of life and Intensive care medicine.
His primary areas of investigation include Internal medicine, Cognition, Glioma, Oncology and Cognitive decline. He has included themes like Neurocognitive and Neuropsychological assessment in his Internal medicine study. His work deals with themes such as Lateralization of brain function, Type 1 diabetes and Magnetoencephalography, which intersect with Cognition.
The study incorporates disciplines such as Clinical trial, Medical physics, Protocol and Medical education in addition to Glioma. His work is dedicated to discovering how Oncology, Hazard ratio are connected with Proportional hazards model and Tumor progression and other disciplines. His studies deal with areas such as Prospective cohort study and Neuropsychology as well as Cognitive decline.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Cognitive deficits in adult patients with brain tumours.
Martin J.B. Taphoorn;Martin Klein.
Lancet Neurology (2004)
Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study
Martin Klein;JJ Heimans;NK Aaronson;HM van der Ploeg.
The Lancet (2002)
Cognitive and radiological effects of radiotherapy in patients with low-grade glioma: long-term follow-up
Linda Douw;Martin Klein;Selene S. A. A. Fagel;Josje van den Heuvel.
Lancet Neurology (2009)
Guidelines on management of low‐grade gliomas: report of an EFNS–EANO* Task Force
R Soffietti;B G Baumert;L Bello;A von Deimling.
European Journal of Neurology (2010)
Epilepsy in low-grade gliomas: the impact on cognitive function and quality of life.
Martin Klein;Nadine H J Engelberts;Henk M van der Ploeg;Dorotheé G A Kasteleijn-Nolst Trenité.
Annals of Neurology (2003)
Lomustine and Bevacizumab in Progressive Glioblastoma
Wolfgang Wick;Thierry Gorlia;Martin Bendszus;Martin Taphoorn.
The New England Journal of Medicine (2017)
Cognitive Rehabilitation in Patients With Gliomas: A Randomized, Controlled Trial
Karin Gehring;Margriet M Sitskoorn;Chad M Gundy;Sietske A M Sikkes.
Journal of Clinical Oncology (2009)
Precuneus atrophy in early-onset Alzheimer's disease: A morphometric structural MRI study
Giorgos Karas;Philip Scheltens;Serge Rombouts;Ronald van Schijndel.
Neurobehavioral Status and Health-Related Quality of Life in Newly Diagnosed High-Grade Glioma Patients
Martin Klein;Martin J.B . Taphoorn;Jan J. Heimans;Henk M. van der Ploeg.
Journal of Clinical Oncology (2001)
Disturbed functional connectivity in brain tumour patients: Evaluation by graph analysis of synchronization matrices
Fabrice Bartolomei;Fabrice Bartolomei;Ingeborg Bosma;Martin Klein;Johannes C. Baayen.
Clinical Neurophysiology (2006)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: